HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward L Hogan Selected Research

Cerebrosides

6/2013Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.
4/2011The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.
6/2010Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward L Hogan Research Topics

Disease

10Multiple Sclerosis
11/2020 - 02/2007
4Inflammation (Inflammations)
01/2018 - 04/2002
4Demyelinating Diseases (Demyelinating Disease)
01/2018 - 02/2007
4Autoimmune Diseases (Autoimmune Disease)
08/2015 - 04/2002
3Infections
06/2013 - 04/2002
3Spinal Cord Injuries (Spinal Cord Injury)
07/2003 - 08/2002
2Parkinson Disease (Parkinson's Disease)
11/2016 - 02/2002
1Oligodendroglioma
11/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2016
1Subacute Sclerosing Panencephalitis (SSPE)
06/2010
1Bacterial Infections (Bacterial Infection)
06/2010
1Encephalitis (Encephalitis, Rasmussen)
06/2010
1Central Nervous System Diseases (CNS Diseases)
06/2010
1Meningitis
06/2010
1Communicable Diseases (Infectious Diseases)
06/2010
1Neuroinflammatory Diseases
03/2009
1Hypoxia (Hypoxemia)
03/2009
1Wounds and Injuries (Trauma)
05/2003
1Meningioma (Meningiomas)
07/2002
1Glioblastoma (Glioblastoma Multiforme)
07/2002
1Astrocytoma (Pilocytic Astrocytoma)
07/2002
1Neoplasms (Cancer)
07/2002
1Brain Neoplasms (Brain Tumor)
07/2002
1Ependymoma
07/2002
1Ganglioglioma
07/2002
1Guillain-Barre Syndrome
04/2002

Drug/Important Bio-Agent (IBA)

6LipidsIBA
01/2018 - 06/2010
5CalpainIBA
11/2016 - 07/2002
5CytokinesIBA
11/2016 - 08/2002
4GlycolipidsIBA
08/2013 - 06/2010
3SphingolipidsIBA
11/2020 - 06/2012
3AntigensIBA
01/2018 - 04/2011
3CeramidesIBA
11/2016 - 03/2009
3CerebrosidesIBA
06/2013 - 06/2010
2Galactosylceramides (Galactocerebrosides)IBA
06/2013 - 06/2013
2Caspase 3 (Caspase-3)IBA
05/2003 - 07/2002
1LigandsIBA
08/2015
1Monoclonal AntibodiesIBA
08/2013
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
06/2012
1NeurotoxinsIBA
03/2009
1Natural Killer Cell ReceptorsIBA
12/2008
1alpha-galactosylceramideIBA
12/2008
1DNA (Deoxyribonucleic Acid)IBA
02/2007
1calpain inhibitorsIBA
05/2003
1Myelin ProteinsIBA
05/2003
1CaspasesIBA
05/2003
1Cysteine Proteases (Cysteine Protease)IBA
05/2003
1Transforming Growth Factor beta (TGF-beta)IBA
08/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2002
1Sepharose (Agarose)IBA
07/2002
1Messenger RNA (mRNA)IBA
07/2002
1Caspase 9IBA
07/2002
1Proteins (Proteins, Gene)FDA Link
07/2002
1RNA (Ribonucleic Acid)IBA
07/2002
1GangliosidesIBA
04/2002
1CarbohydratesIBA
04/2002
1LipopolysaccharidesIBA
04/2002
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
02/2002

Therapy/Procedure

1Therapeutics
01/2018
1Immunomodulation
08/2013
1Radiotherapy
07/2002
1Drug Therapy (Chemotherapy)
07/2002